Repeat-Dose Pharmacokinetics Study of NRL-1 in Epilepsy Subjects

Clinical trial NCT02724423 · COMPLETED

Trial details

NCT number: NCT02724423
Sponsor: Neurelis, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Repetitive Seizures

Start date: 2016-06-30
Primary completion: 2019-04-10
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.